Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medium chain triglyceride therapy for citrin deficiency
jRCTs041190017Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of medium-chain triacylglycerol oil in citrin deficiency and citrullinemia type 2 (CTLN2), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Improvement of clinical symptoms and quality of life. Started Jul 2012; status: recruiting.
02
Drugs
medium-chain triacylglycerol oil
03
Conditions
citrin deficiencycitrullinemia type 2 (CTLN2)
Beyond the preview
Go deeper on jRCTs041190017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190017.